…deep dive on gene-editing tools or an overview of the startup ecosystem in Europe. Our reports will explore all the corners of the biotech industry in an easy-to-read format so…
…sectors, and I believe we will see no shortage of life sciences startup exits in the upcoming decade. With the growth of startups and investments in biomanufacturing, Lithuania could become…
…many algae biofuel companies about a decade ago dealt a blow to the field that it still has trouble recovering from. The biofuel disaster The early 2010s saw several startups…
…startups or other commercialization opportunities. The company has an impressive track record helping biotech startups such as Achilles Therapeutics, Autolus Therapeutics and Orchard Therapeutics, among others, to launch and go…
…its work on precision RNA therapeutics that it will use to remodel suboptimal livers. The startup combines computation, automation and deep phenotyping to develop drugs for liver diseases. Quin Wills,…
…contents Top biotech M&As of March 2025 Among the top mergers and acquisitions (M&As) last month was AstraZeneca’s billion-dollar buyout of Belgian biotech EsoBiotec. The startup has come up with…
…the center plans to continue funding startups over the next five years. Some notable examples of startups springing from DTU Biosustain in the past include: BioPhero, a biotech that uses…
A survey of synbio startups in the last 16 years shows that the UK ecosystem is growing rapidly and approaching critical mass, says SynbiCITE. Dedicated to championing industrial uptake of…
…Developing a Tech Startup Free Enrollment every month Hosted by Coursera and run by the École Polytechnique and HEC Paris, France This online course is aimed at those forming companies…
…founding startups. According to Franck Lescure at Elaia, though, the difference in technology doesn’t mean that the two can’t mix. “There is no incompatibility between digital and life sciences, and…
…Incubator has received numerous requests from international startups and innovators hoping to benefit from its experience in developing life science business ideas. In response, it is now launching the UBI…
…its potential in cancer and neurodegenerative diseases. The startup has raised $60.5 million in funds to date. BridgeBio Oncology Therapeutics Disease area: cancer Technology: RAS signaling Recent funding: $200 million…